GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Omnicell Inc (NAS:OMCL) » Definitions » Price-to-Free-Cash-Flow

OMCL (Omnicell) Price-to-Free-Cash-Flow : 12.92 (As of Jul. 04, 2025)


View and export this data going back to 2001. Start your Free Trial

What is Omnicell Price-to-Free-Cash-Flow?

As of today (2025-07-04), Omnicell's share price is $29.84. Omnicell's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2025 was $2.31. Hence, Omnicell's Price-to-Free-Cash-Flow Ratio for today is 12.92.

The historical rank and industry rank for Omnicell's Price-to-Free-Cash-Flow or its related term are showing as below:

OMCL' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 7.5   Med: 42.08   Max: 382.23
Current: 12.92

During the past 13 years, Omnicell's highest Price-to-Free-Cash-Flow Ratio was 382.23. The lowest was 7.50. And the median was 42.08.

OMCL's Price-to-Free-Cash-Flow is ranked better than
60.2% of 397 companies
in the Healthcare Providers & Services industry
Industry Median: 16.29 vs OMCL: 12.92

Omnicell's Free Cash Flow per Share for the three months ended in Mar. 2025 was $0.22. Its Free Cash Flow per Share for the trailing twelve months (TTM) ended in was $2.31.

During the past 12 months, the average Free Cash Flow per Share Growth Rate of Omnicell was -36.00% per year. During the past 3 years, the average Free Cash Flow per Share Growth Rate was -6.90% per year. During the past 5 years, the average Free Cash Flow per Share Growth Rate was -1.30% per year.

During the past 13 years, Omnicell's highest 3-Year average Free Cash Flow per Share Growth Rate was 189.20% per year. The lowest was -55.10% per year. And the median was 29.70% per year.


Omnicell Price-to-Free-Cash-Flow Historical Data

The historical data trend for Omnicell's Price-to-Free-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Omnicell Price-to-Free-Cash-Flow Chart

Omnicell Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Price-to-Free-Cash-Flow
Get a 7-Day Free Trial Premium Member Only Premium Member Only 40.07 49.87 135.90 13.49 15.26

Omnicell Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Price-to-Free-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.10 8.17 16.91 15.26 15.14

Competitive Comparison of Omnicell's Price-to-Free-Cash-Flow

For the Health Information Services subindustry, Omnicell's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Omnicell's Price-to-Free-Cash-Flow Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Omnicell's Price-to-Free-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Omnicell's Price-to-Free-Cash-Flow falls into.


;
;

Omnicell Price-to-Free-Cash-Flow Calculation

Omnicell's Price-to-Free-Cash-Flow ratio for today is calculated as

Price-to-Free-Cash-Flow Ratio=Share Price/ Free Cash Flow per Share (TTM)
=29.84/2.309
=12.92

Omnicell's Share Price of today is $29.84.
Omnicell's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $2.31.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

Price-to-Free-Cash-Flow Ratio=Market Cap/Free Cash Flow

Omnicell  (NAS:OMCL) Price-to-Free-Cash-Flow Explanation

Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.

In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.


Be Aware

In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.


Omnicell Price-to-Free-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Omnicell's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Omnicell Business Description

Traded in Other Exchanges
N/A
Address
4220 North Freeway, Fort Worth, Santa Clara, CA, USA, 76137
Omnicell Inc provides automation and business analytics software for healthcare providers. The company is engaged in transforming the pharmacy and nursing care delivery model. The company helps its customers define and deliver cost-effective medication management designed to equip and empower pharmacists and nurses to focus on patient care rather than administrative tasks and drive improved clinical, operational, and financial outcomes across all care settings. The company derives the majority of its revenue from the United States.
Executives
Randall A Lipps director, officer: President and CEO 1101 EAST MEADOW DR, PALO ALTO CA 94303
Mark W Parrish director BUILDING 4, TRIDENT PLACE, MOSQUITO WAY, HATFIELD, HERTFORDSHIRE X0 AL10 9UL
Kaushik Ghoshal director 9001 SPECTRUM CENTER BLVD, SAN DIEGO CA 92123
Christine Marie Mellon officer: EVP, Chief People Officer 590 E. MIDDLEFIELD ROAD, MOUNTAIN VIEW CA 94043
Nchacha Etta officer: EVP & CFO 4220 NORTH FREEWAY, FORT WORTH TX 76137
Joanne B Bauer director 1400 HOLCOMB BRIDGE ROAD, ROSWELL GA 30076-2199
Scott Peter Seidelmann officer: EVP, Chief Commercial Officer 590 E. MIDDLEFIELD ROAD, MOUNTAIN VIEW CA 94043
Peter J. Kuipers officer: Executive V.P. CFO 590 E. MIDDLEFEILD ROAD, MOUNTAIN VIEW CA 94043
Mary Garrett director ETHAN ALLEN DRIVE, DANBURY CT 06811
Manley Corey J officer: SR. VP & CHIEF LEGAL OFFICER 590 E. MIDDLEFIELD ROAD, MOUNTAIN VIEW CA 94043
Dan S Johnston officer: V.P., Legal & General Counsel
Joseph Brian Spears officer: Chief Accounting Officer & VP 590 E. MIDDLEFIELD ROAD, MOUNTAIN VIEW CA 94043
James T Judson officer: VP Finance & Acting CFO C/O OMNICELL, INC., 1201 CHARLESTON ROAD, MOUNTAIN VIEW CA 94043
Robin Gene Seim officer: V.P., Finance & CFO 1201 CHARLESTON ROAD, MOUNTAIN VIEW CA 94043
Edward Peter Bousa director 280 CONGRESS STREET, BOSTON MA 02210